Role of Fc fragments in inhibition of xenogenic hyperacute rejection by intravenous immunoglobulin

Transplantation

Volumn 62, Issue 5, 1996, Pages 559-562

  Kojima, Taiki ^a   Hayashi, Shuji ^a   Yokoyama, Itsuo ^a   Takagi, Hiroshi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA VENIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GUINEA PIG; HEART TRANSPLANTATION; HEMAGGLUTINATION; HEMOLYSIS; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM;

EID: 0029812954     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199609150-00003     Document Type: Article

References (14)

1. Dalmasso AP, Bach FH, Platt JL, et al. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Med 1992; 140: 1157.
2. Miyagawa S, Hirose H, Kitamura H, et al. The mechanism of discordant xenograft rejection. Transplantation 1988; 46: 825.
3. Gautreau C, Kojima T, Houssin D, et al. Use of intravenous immunoglobulin to delay xenogenic hyperacute rejection. Transplantation 1995; 60: 903.
4. Deutsch HF, Stiehm ER, Morton JI. Action of papain on human serum globulins. J Biochem Commun 1961; 236: 2216.
5. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
6. Leventhal JR, Dalmasso AP, Bach FH, et al. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993; 56: 1.
7. Pruitt SK, Baldwin WM, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 1994; 57: 90.
8. Joy Yang YH, Ngo C, Uemura Y, et al. Antibody Fc functional activity of intravenous immunoglobulin preparation treated with solvent-detergent for virus inactivation. Vox Sang 1994; 67: 337.
9. Toyoda M, Zhang XM, Jordan SC, et al. Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin. Transpl Immunol 1994; 2: 337.
10. Dalmasso AP, Platt JL. Prevention of complement-mediated activation of xenogenic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation 1993; 56: 1171.
11. Stohl W. Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogeninduced B-cell differentiation. Clin Exp Immunol 1985; 62: 200.
12. Debre M, Bonnet MC, Griscelli C, et al. Infusion of Fc fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 1993; 342: 945.
13. Schaapherder AFM, Daha MR, Gooszen HG, et al. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57: 1376.
14. Magee JC, Bollinger RR, Frank MM, et al. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin. Transplant Proc 1995; 27: 271.